Humana (NYSE:HUM) Downgraded by Piper Sandler
Piper Sandler lowered shares of Humana (NYSE:HUM – Free Report) from an overweight rating to a neutral rating in a research note published on Thursday, Marketbeat reports. Piper Sandler currently has $274.00 price target on the insurance provider’s stock, down from their previous price target of $392.00. A number of other analysts have also weighed […]
7 Oct 09:27 · The Markets Daily